跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MC-5
首页
药物
MC-5
MC-5
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
SUBSTITUTED AROMATIC COMPOUNDS
EP 2970089 B1
申请人: PROMETIC PHARMA SMT LTD
优先权: 2013
CN
EP
US
WO
8 件公开
SUBSTITUTED AROMATIC COMPOUNDS FOR THE TREATMENT OF PULMONARY FIBROSIS, LIVER FIBROSIS, SKIN FIBROSIS AND CARDIAC FIBROSIS
EP 2970088 B1
申请人: PROMETIC PHARMA SMT LTD
优先权: 2013
EP
US
WO
6 件公开
Melanocortin receptor ligands
US 6911447 B2
申请人: PROCTER & GAMBLE
优先权: 2001
CN
US
5 件公开
US 2006128613 A1
申请人: PROCTER & GAMBLE
优先权: 2003
US
SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DIABETES
EP 3203998 B1
申请人: LIMINAL BIOSCIENCES LTD
优先权: 2014
CN
EP
US
3 件公开
Pyrrolopyrimidine A2B selective antagonist compounds, their synthesis and use
US 7645754 B2
申请人: OSI PHARM INC
优先权: 2001
CN
US
3 件公开
METHOD OF TREATING HAIR LOSS USING SULFONYL THYROMIMETIC COMPOUNDS
WO 0072810 A1
申请人: UNIV TEXAS SOUTHWESTERN MED CT
优先权: 1999
US
WO
2 件公开
Angiogenesis inhibitors
US 2003186996 A1
申请人: TENG CHE-MING
优先权: 2002
CN
US
2 件公开
Photo-curable reparative material for dental use
US 6849670 B2
申请人: TOKUYAMA CORP
优先权: 2000
US
2 件公开
METHOD FOR DETERMINING 5-METHYLCYTOSINE CONFIGURATIONS IN DNA
EP 3845554 A1
申请人: UNIV DORTMUND TECH
优先权: 2019
EP
2 件公开
Indolyl-2-phenyl bisamidines useful as antiproliferative agents
US 6699862 B1
申请人: PFIZER
优先权: 2000
US
第 1 / 5 页
上一页
下一页
药物
反馈